N/A
N=55
NBI to Detect Post-RT Mucosal Residual NPC
Nasopharyngeal Carcinoma
Bottom Line
View on ClinicalTrials.gov: NCT02584790 ↗Enrolled (actual)
55
Serious AEs
0.0%
Results posted
Oct 2017
Primary outcome: Primary: Positive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC Patient — 14; 1; 20; 1 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Laryngoscope with NBI system (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Pamela Youde Nethersole Eastern Hospital
- Primary completion
- Apr 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Positive Nasopharynx Biopsy Results Detected by NBI System in Those Post-radiotherapy 8th Week NPC Patient |
14; 1; 20; 1; 1; 1 | — |
| SECONDARY Assocication of Residual NPC With NBI Non Suspicious Pattern Group and NBI Suspicious Pattern Group |
34; 2; 2; 2 | 0.004 sig |
| SECONDARY The Sensitivity, Specificity, Positive Predicted Valve and Negative Predicted Valve of Detecting Mucosal Residual NPC Using NBI Suspicious/ Non Suspicous Pattern |
50; 50; 94; 94 | — |
Summary
NBI has been proven to be a useful tool to detect early NPC, but they were few studies concerning the detection of post-radiotherapy mucosal residual NPC using NBI system
Eligibility Criteria
Inclusion Criteria
- all new NPC patient
Exclusion Criteria
- History of radiotherapy to head and neck region
- Poor premorbid status/ non-communicable patients
- <18 years old
- Pregnancy
Data sourced from ClinicalTrials.gov (NCT02584790). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.